DHR:NYE-Danaher Corporation (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 272.63

Change

0.00 (0.00)%

Market Cap

USD 199.35B

Volume

9.26M

Analyst Target

USD 220.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IQV IQVIA Holdings Inc

N/A

USD 43.52B
A Agilent Technologies Inc

N/A

USD 40.25B
LH Laboratory Corporation of Amer..

N/A

USD 18.96B
DGX Quest Diagnostics Incorporated

N/A

USD 17.31B
CRL Charles River Laboratories

N/A

USD 10.65B
QGEN Qiagen NV

N/A

USD 9.98B
VNRX Volitionrx Ltd

N/A

USD 0.06B
ENZ Enzo Biochem Inc

N/A

USD 0.06B
TMO Thermo Fisher Scientific Inc

N/A

N/A
MTD Mettler-Toledo International I..

N/A

N/A

ETFs Containing DHR

SYNB Putnam Biorevolution ETF 7.44 % 0.00 %

N/A

USD 5.43M
AILG 6.99 % 0.00 %

N/A

N/A
DXSF:XETRA Xtrackers - Stoxx Europe .. 5.91 % 0.00 %

N/A

USD 0.08B
LIFE-U:CA Evolve Global Healthcare .. 5.53 % 0.00 %

N/A

N/A
LIFE:CA Evolve Global Healthcare .. 5.09 % 0.69 %

N/A

CAD 0.22B
ZWHC:CA BMO Covered Call Health C.. 4.69 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.55 % 0.00 %

N/A

USD 0.15B
BCHP 4.40 % 0.00 %

N/A

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.17 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.11 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 4.06 % 0.00 %

N/A

N/A
SANE 3.95 % 0.00 %

N/A

N/A
XLV Health Care Select Sector.. 3.18 % 0.13 %

N/A

USD 42.10B
QDVG:XETRA iShares S&P 500 Health Ca.. 3.17 % 0.00 %

N/A

USD 2.05B
XUHC:F Xtrackers (IE) Public Lim.. 3.16 % 0.00 %

N/A

USD 0.85B
XUHC:SW Xtrackers MSCI USA Health.. 3.16 % 0.00 %

N/A

USD 0.69B
SXLV:SW SPDR S&P U.S. Health Care.. 3.07 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.06 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.06 % 0.00 %

N/A

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 3.06 % 0.00 %

N/A

USD 0.40B
CNEQ The Alger ETF Trust 2.83 % 0.00 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 2.78 % 0.08 %

N/A

USD 3.01B
HIUS:PA HSBC MSCI USA Islamic ESG.. 2.78 % 0.00 %

N/A

N/A
HIUA:SW HSBC MSCI USA Islamic ESG.. 2.78 % 0.00 %

N/A

USD 0.03B
INNO Harbor Disruptive Innovat.. 2.76 % 0.00 %

N/A

N/A
USRI:PA AMUNDI MSCI USA SRI Clima.. 2.72 % 0.00 %

N/A

USD 1.96B
WEBD:XETRA AETF-MUSCNZAP EOA ETF 2.72 % 0.00 %

N/A

N/A
USRI:LSE 2.50 % 0.00 %

N/A

N/A
DSAE:CA Desjardins Sustainable Am.. 2.34 % 0.00 %

N/A

CAD 1.22M
UBUS:F UBS (Irl) ETF Public Limi.. 2.31 % 0.00 %

N/A

USD 0.18B
UBUW:F UBS (Irl) ETF Public Limi.. 2.31 % 0.00 %

N/A

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 0.05B
UPVLE:SW UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 0.02B
UPVLD:SW UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 0.17B
UPVLH:SW UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 8.19M
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.30 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.20 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.20 % 0.00 %

N/A

N/A
XAMB:F Amundi Index Solutions - .. 1.53 % 0.00 %

N/A

N/A
HYLG Global X Funds - Global X.. 1.44 % 0.00 %

N/A

N/A
LESW:LSE 1.38 % 0.00 %

N/A

N/A
WSRI:LSE 1.30 % 0.00 %

N/A

N/A
WELB:XETRA Amundi MSCI ACWI SRI PAB .. 1.08 % 0.00 %

N/A

N/A
EMWE:PA BNP Paribas Easy MSCI Wor.. 0.91 % 0.00 %

N/A

USD 0.78B
EWRD:PA BNP Paribas Easy MSCI Wor.. 0.91 % 0.00 %

N/A

USD 0.09B
EMWE:XETRA BNP Paribas Easy MSCI Wor.. 0.91 % 0.00 %

N/A

USD 0.55B
RAVI FlexShares Ready Access V.. 0.86 % 0.25 %

N/A

USD 1.08B
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

N/A

USD 0.20B
CWW.A:CA 0.00 % 1.49 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

N/A

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
JMIN 0.00 % 0.12 %

N/A

N/A
EVSTC 0.00 % 0.00 %

N/A

N/A
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

N/A

CAD 0.05B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.01B
LS:CA 0.00 % 2.21 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

N/A
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.89 %

N/A

CAD 0.02B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

N/A

USD 2.54B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.17B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 8.30M
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.68B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.68B
EMWE:F BNP Paribas Easy - MSCI W.. 0.00 % 0.00 %

N/A

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
EWRD:XETRA 0.00 % 0.00 %

N/A

N/A
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
NUSA:CA NBI Active U.S. Equity ET.. 0.00 % 0.00 %

N/A

CAD 0.05B
XOUT 0.00 % 0.00 %

N/A

N/A
USXF iShares® ESG Advanced MS.. 0.00 % 0.00 %

N/A

USD 1.14B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.09B
PFUT Putnam Sustainable Future.. 0.00 % 0.00 %

N/A

USD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.85% 100% F 77% C+
Dividend Return 0.23% 43% F 4% F
Total Return 18.08% 100% F 73% C
Trailing 12 Months  
Capital Gain 9.77% 38% F 41% F
Dividend Return 0.42% 43% F 4% F
Total Return 10.19% 38% F 33% F
Trailing 5 Years  
Capital Gain 88.54% 83% B 84% B
Dividend Return 3.11% 40% F 9% A-
Total Return 91.65% 83% B 82% B
Average Annual (5 Year Horizon)  
Capital Gain 13.35% 54% F 75% C
Dividend Return 13.74% 54% F 71% C-
Total Return 0.39% 43% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 29.29% 54% F 35% F
Risk Adjusted Return 46.90% 62% D 64% D
Market Capitalization 199.35B 100% F 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.